Abstract
A Summary of Viral Targets and Recently Released PDB IDs of SARS-CoV-2
Highlights
Drug discovery and development against coronavirus disease 2019 (COVID-19) is the utmost need and the most challenging task of the hour
There are only a few Protein Data Bank (PDB) Ids available related to SARS-CoV-2 in the RCSB database
The proteases represent a relevant target for designing drugs against SARS-CoV-2
Summary
A Summary of Viral Targets and Recently Released PDB IDs of SARS-CoV-2 Drug discovery and development against coronavirus disease 2019 (COVID-19) is the utmost need and the most challenging task of the hour. There is an urgent need to identify specific targets to design promising therapeutic agents against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. Analysis of SARS-CoV-2 reveals seven major target proteins that can be considered for drug design against the virus.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
